Abiopharma

Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2026

Genco Shipping & Trading Files Preliminary Proxy Statement in Connection with 2026 Annual Meeting of Shareholders

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

SLB Announces First-Quarter 2026 Results

Kontoor Brands Declares Quarterly Dividend

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

W&T Offshore Announces Timing of First Quarter 2026 Earnings Release and Conference Call

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Rithm Property Trust Inc. Announces First Quarter 2026 Results

Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe